EGFR and neoplasm: In preoperative radiotherapy, Zlobec et al reported that a completepathological response was about 6 times more likely in epidermal growth factor receptor(EGFR)-positive cases than in EGFR-negative cases.32 From this point of view, only patients with lower EGFR status may need a higher SBRTdose to achieve better treated tumor control.